Beta-Cell Function and Sitagliptin Trial (BEST)

NCT00420511 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Sitagliptin
DRUG: Placebo
DRUG: metformin

Sponsor

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

Collaborators

[object Object]